Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y 12 Inhibitors and Their Association with Platelet Function.

Autor: Gumiężna, Karolina, Bednarek, Adrian, Sygitowicz, Grażyna, Maciejak-Jastrzębska, Agata, Baruś, Piotr, Hunia, Jaromir, Klimczak-Tomaniak, Dominika, Kochman, Janusz, Grabowski, Marcin, Tomaniak, Mariusz

Publikováno v: Journal of Clinical Medicine; Jan2024, Vol. 13 Issue 1, p63, 11p

Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20 ⁺ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models.

Autor: Domka K; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw., Dąbkowska A; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw., Janowska M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw., Urbańska Z; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland; Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz., Pastorczak A; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland; Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz., Winiarska M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw., Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw., Lachota M; Laboratory of Cellular and Genetic Therapies, Medical University of Warsaw, Warsaw, Poland; Department of Ophthalmology, Children's Memorial Health Institute, Warsaw., Patkowska E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw., Sędek Ł; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice., Perkowski B; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice., Hunia J; Department of Immunology, Medical University of Warsaw, Warsaw., Jakubowska J; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz., Krzymieniewska B; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw., Lech-Marańda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw., Młynarski W; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz., Szczepański T; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice., Firczuk M; Laboratory of Immunology, Mossakowski Medical Research Institute Polish Academy of Sciences, Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Warsaw. mfirczuk@imdik.pan.pl.

Publikováno v: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3520-3532. Date of Electronic Publication: 2024 Nov 01.